BioPlex 2200 ANA Screen with MDSS

BioPlex 2200 ANA Screen with MDSS

This multiplex test panel detects and differentiates clinically relevant antinuclear antibodies used to aid in diagnosing connective tissue diseases (CTDs). The MDSS Software may be used to associate positive ANA result profiles with specific CTDs. 

Read more
Ordering information

Overview

The BioPlex 2200 ANA Screen uses multiplex technology to generate up to 14 individual results per test: a composite ANA screen result plus up to 13 ANA analyte results.

ANA-pack-beads
BioPlex 2200 ANA Screen Panel

1 Test = 14 Individual Results

With the fully automated BioPlex 2200 System, the BioPlex 2200 ANA Screen can provide up to 1,400 individual results per hour and eliminates separate follow-up testing to help clinical laboratories streamline workflow, automate testing processes, and manage ANA workloads better.

Each BioPlex 2200 ANA Screen reagent pack uses multiplex technology to deliver up to 14 results:

  • ANA screen result
  • Ribosomal protein
  • SS-B
  • RNP At
  • Centromere B
  • dsDNA (quantitative)
  • SS-A 52*
  • Sm
  • RNP 68
  • Jo-1
  • Chromatin
  • SS-A 60*
  • Sm/RNP
  • Scl-70

* SS-A (52 and 60) is reported as a composite results in the U.S.
† RNP (A and 68) is reported as a composite results in the U.S.
‡ Composite result.

Optimize ANA Workflows

Optimize ANA Workflows

With full automation and multiplex technology, clinical laboratories can maximize autoantibody testing efficiency. Multiplexing takes full automation to the next level by allowing labs to complete ANA screening and follow-up testing in one step.

Reduce Operational Costs

Reduce Operational Costs

ANA testing using IFA or other traditional EIA methods requires initial screening and multiple follow-up tests. In comparison, multiplexed ANA panels enable labs to use a single test to complete ANA screening and follow-up testing. Labs can expand in-house ANA testing menus and reduce send-out testing costs, all while using fewer reagents, calibrators, controls, and consumable supplies.

Improve Patient Care

Improve Patient Care

By conducting an ANA screen and follow-up testing in a single step, labs can dramatically enhance result turnaround time and provide better patient care. Additionally, integrated quality control beads monitor assay parameters in real time to ensure the integrity of every test.

You May Also Be Interested In:

Ordering

items

Use the filters below to refine results!

Image
bpx_665_1150_tn.jpg
665-1150
Reagents for 100 tests for clinically relevant antinuclear autoantibodies on BioPlex 2200 System; aids in diagnosis of systemic rheumatic diseases
Image
bpx_663_1101_tn.jpg
663-1101
Multiplex calibrators for calibration of results of ANA Screen testing on the BioPlex 2200 System
Image
bpx_663_1131_tn.jpg
663-1131
Set of multiplex negative and multi-analyte positive controls for ANA testing on the BioPlex 2200 System

Documents

Number Description
Add to Cart (Free)
Add to Cart (Free)
Add to Cart (Free)
Add to Cart (Free)